Mining bacterial genomes reveals valuable ‘hidden’ drugs

A new tool to excavate bacterial genomes that potentially hide a rich array of pharmaceutical treasures has led to the discovery of a novel antibiotic. The study, reported in the August issue of Microbiology, could lead to new treatments for serious diseases that are rapidly acquiring multi-drug resistance.

Read more

New insights into how stem cells determine what tissue to become

ANN ARBOR, Mich.—Within 24 hours of culturing adult human stem cells on a new type of matrix, University of Michigan researchers were able to make predictions about how the cells would differentiate, or what type of tissue they would become. Their results are published in the Aug. 1 edition of Nature Methods.

Read more

Epileptic seizures may be linked to an ancient gene family

New research points to a genetic route to understanding and treating epilepsy. Timothy Jegla, an assistant professor of biology at Penn State University, has identified an ancient gene family that plays a role in regulating the excitability of nerves within the brain.

Read more

UCSD scientists find controls for uncontrolled cell growth

Researchers at the University of California, San Diego School of Medicine have identified a new way to regulate the uncontrolled growth of blood vessels, a major problem in a broad range of diseases and conditions.

Read more

A potential chemotherapeutic drug to treat hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, particularly in China. However, HCC remains one of the more difficult cancers to treat. It is important to screen for new anti-cancer drugs. A number of dietary compounds possess anti-cancer properties. These dietary compounds may modify the activity of specific targets that control cell proliferation and apoptosis. Galangin could inhibit the methoxyresorufin O-demethylase activity of CYP1A2, CYP1A1 and P-form phenolsulfotransferase. Galangin induced apoptosis in several cancer cell lines and arrested the cell cycle, modulated the expression of cycline/cdk, and decreased Bcl-2. It was suggested that galangin may be a potential anti-tumor agent. However, the mechanism by which galangin exerts its anti-tumor activity is unknown.

Read more

30 million women to benefit from health reform law

Premium subsidies, bans on higher premiums and coverage denials based on gender, and required maternity and newborn care coverage among most significant in reducing women’s exposure to health costs

Read more

Vanishing bile duct syndrome secondary to anti-retroviral therapy in HIV

Vanishing bile duct syndrome (VBDS) refers to a group of disorders characterized by destruction and disappearance of intrahepatic (inside the liver) bile ducts. Multiple causes have been identified including infections, malignancies, autoimmune conditions and adverse effects of medications. The usual course of this condition is variable and many patients with VBDS respond to treatment of the underlying condition and/ or removal of the offending agent. However, others progress to cirrhosis and end stage liver disease requiring liver transplantation.

Read more

Functional magnetic resonance imaging to evaluate pancreatic cancer

Pancreatic ductal adenocarcinoma (the disease commonly referred to as pancreatic cancer) carries the worst prognosis of any cancer. As current treatments offer minimal benefit, entirely new approaches are needed. Given the success of local therapies, as opposed to intravenous systemic therapies, for liver diseases (such as hepatocellular carcinoma), it is thought that similar local therapies may benefit patients with pancreatic cancer. To develop such therapies, it would be useful to devise targets that are easy to obtain and can indicate the efficacy of these new therapies in models of pancreatic cancer.

Read more

Western diet link to ADHD

A new study from Perth’s Telethon Institute for Child Health Research shows an association between ADHD and a ‘Western-style’ diet in adolescents.

The research findings have just been published online in the international Journal of Attention Disorders.

Read more

New lab test could identify imatinib resistance

PHILADELPHIA — Scientists in Japan may have developed a way to accurately predict those patients who will resist treatment with imatinib, which is the standard of care for chronic myeloid leukemia (CML).

Read more

Next Page »